276 related articles for article (PubMed ID: 18928409)
1. Tumor suppressors, chromosomal instability, and hepatitis C virus-associated liver cancer.
McGivern DR; Lemon SM
Annu Rev Pathol; 2009; 4():399-415. PubMed ID: 18928409
[TBL] [Abstract][Full Text] [Related]
2. Tumor-promoting/progressing role of additional chromosome instability in hepatic carcinogenesis in Sgo1 (Shugoshin 1) haploinsufficient mice.
Yamada HY; Zhang Y; Reddy A; Mohammed A; Lightfoot S; Dai W; Rao CV
Carcinogenesis; 2015 Apr; 36(4):429-40. PubMed ID: 25740822
[TBL] [Abstract][Full Text] [Related]
3. Aberrant cyclin A expression and centrosome overduplication induced by hepatitis B virus pre-S2 mutants and its implication in hepatocarcinogenesis.
Wang LH; Huang W; Lai MD; Su IJ
Carcinogenesis; 2012 Feb; 33(2):466-72. PubMed ID: 22159224
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of proproliferative genes and the ligand/receptor pair placental growth factor and vascular endothelial growth factor receptor 1 in hepatitis C cirrhosis.
Huang XX; McCaughan GW; Shackel NA; Gorrell MD
Liver Int; 2007 Sep; 27(7):960-8. PubMed ID: 17696935
[TBL] [Abstract][Full Text] [Related]
5. [Hepatitis C virus infection and hepatocarcinogenesis].
Szalay F
Orv Hetil; 2010 Sep; 151(38):1524-9. PubMed ID: 20826376
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus x protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma.
Kew MC
J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():144-52. PubMed ID: 21199526
[TBL] [Abstract][Full Text] [Related]
7. RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County.
Xue WJ; Li C; Zhou XJ; Guan HG; Qin L; Li P; Wang ZW; Qian HX
J Gastroenterol Hepatol; 2008 Sep; 23(9):1448-58. PubMed ID: 17683489
[TBL] [Abstract][Full Text] [Related]
8. [Hepatocellular carcinoma: molecular biology aspects].
Blum HE
Zentralbl Chir; 1994; 119(11):759-63. PubMed ID: 7846955
[TBL] [Abstract][Full Text] [Related]
9. Promyelocytic leukaemia protein links DNA damage response and repair to hepatitis B virus-related hepatocarcinogenesis.
Chung YL; Wu ML
J Pathol; 2013 Aug; 230(4):377-87. PubMed ID: 23620081
[TBL] [Abstract][Full Text] [Related]
10. Diverse roles of hepatitis B virus in liver cancer.
Fallot G; Neuveut C; Buendia MA
Curr Opin Virol; 2012 Aug; 2(4):467-73. PubMed ID: 22722078
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus core protein inhibits tumor suppressor protein promyelocytic leukemia function in human hepatoma cells.
Herzer K; Weyer S; Krammer PH; Galle PR; Hofmann TG
Cancer Res; 2005 Dec; 65(23):10830-7. PubMed ID: 16322229
[TBL] [Abstract][Full Text] [Related]
12. Pathways and gene expression profiles in hepatocellular carcinoma.
Facciorusso A; Nacchiero MC; Rosania R; Laonigro G; Giorgio F; Del Prete V; Panella C; Ierardi E
Minerva Gastroenterol Dietol; 2012 Mar; 58(1):35-48. PubMed ID: 22419003
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus pre-S2 mutant large surface protein inhibits DNA double-strand break repair and leads to genome instability in hepatocarcinogenesis.
Hsieh YH; Chang YY; Su IJ; Yen CJ; Liu YR; Liu RJ; Hsieh WC; Tsai HW; Wang LH; Huang W
J Pathol; 2015 Jul; 236(3):337-47. PubMed ID: 25775999
[TBL] [Abstract][Full Text] [Related]
14. Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections.
Tornesello ML; Buonaguro L; Tatangelo F; Botti G; Izzo F; Buonaguro FM
Genomics; 2013 Aug; 102(2):74-83. PubMed ID: 23583669
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profiling of hepatitis B- and hepatitis C-related hepatocellular carcinoma using graphical Gaussian modeling.
Ueda T; Honda M; Horimoto K; Aburatani S; Saito S; Yamashita T; Sakai Y; Nakamura M; Takatori H; Sunagozaka H; Kaneko S
Genomics; 2013 Apr; 101(4):238-48. PubMed ID: 23485556
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of HBV-associated hepatocarcinogenesis.
Guerrieri F; Belloni L; Pediconi N; Levrero M
Semin Liver Dis; 2013 May; 33(2):147-56. PubMed ID: 23749671
[TBL] [Abstract][Full Text] [Related]
17. Predictive power of biomarkers of oxidative stress and inflammation in patients with hepatitis C virus-associated hepatocellular carcinoma.
Maki A; Kono H; Gupta M; Asakawa M; Suzuki T; Matsuda M; Fujii H; Rusyn I
Ann Surg Oncol; 2007 Mar; 14(3):1182-90. PubMed ID: 17195915
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus x protein and pin1 in liver cancer: "les liaisons dangereuses".
Avila MA; Lu KP
Gastroenterology; 2007 Mar; 132(3):1180-3. PubMed ID: 17383439
[No Abstract] [Full Text] [Related]
19. Hepatitis C virus NS3 protein modulates the biological behaviors of malignant hepatocytes by altering the expression of host cell microRNA.
Zhang J; Ishigaki Y; Takegami T
Mol Med Rep; 2015 Oct; 12(4):5109-15. PubMed ID: 26151503
[TBL] [Abstract][Full Text] [Related]
20. Alterations of RB1, p53 and Wnt pathways in hepatocellular carcinomas associated with hepatitis C, hepatitis B and alcoholic liver cirrhosis.
Edamoto Y; Hara A; Biernat W; Terracciano L; Cathomas G; Riehle HM; Matsuda M; Fujii H; Scoazec JY; Ohgaki H
Int J Cancer; 2003 Sep; 106(3):334-41. PubMed ID: 12845670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]